SELLAS Life Sciences Group, Inc.

SLS · Nasdaq · SIC 2834: Pharmaceutical Preparations
432
SEC Filings

Business Summary

PART I Overview We are a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. Our product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and SLS009 (tambiciclib), a highly selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. Galinpepimut-S: Highly Novel and Engineered Immunotherapy Targeting the WT1 Antigen Our le...

Next Earnings

Q2 FY2026 — expected 2026-09-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSLSdiscussed_in_filing Artificial Intelligence
topic_mentionSLSdiscussed_in_filing Cybersecurity
topic_mentionSLSdiscussed_in_filing Trusted Computing
topic_mentionSLSdiscussed_in_filing Blockchain & Crypto
topic_mentionSLSdiscussed_in_filing Regulation
topic_mentionSLSdiscussed_in_filing Automotive
topic_mentionSLSdiscussed_in_filing Healthcare & Bio
topic_mentionSLSdiscussed_in_filing Platform & Ecosystem
topic_mentionSLSdiscussed_in_filing Sovereign & Government
topic_mentionSLSdiscussed_in_filing Artificial Intelligence
topic_mentionSLSdiscussed_in_filing Cybersecurity
topic_mentionSLSdiscussed_in_filing Trusted Computing
topic_mentionSLSdiscussed_in_filing Blockchain & Crypto
topic_mentionSLSdiscussed_in_filing Regulation
topic_mentionSLSdiscussed_in_filing Automotive
topic_mentionSLSdiscussed_in_filing Healthcare & Bio
topic_mentionSLSdiscussed_in_filing Platform & Ecosystem
topic_mentionSLSdiscussed_in_filing Sovereign & Government
topic_mentionSLSdiscussed_in_filing Artificial Intelligence
topic_mentionSLSdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001390478-26-000003EDGAR101K words
2025-03-202024-12-310001390478-25-000003EDGAR—
2024-03-282023-12-310001390478-24-000004EDGAR—
2023-03-162022-12-310001390478-23-000005EDGAR—
2022-03-312021-12-310001390478-22-000006EDGAR—
2021-03-232020-12-310001390478-21-000007EDGAR—
2020-03-132019-12-310001390478-20-000007EDGAR—
2019-03-222018-12-310001390478-19-000017EDGAR—
2018-04-132017-12-310001193125-18-117053EDGAR—
2017-03-152016-12-310001390478-17-000020EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001390478-25-000020EDGAR16K words
2025-08-122025-06-300001390478-25-000016EDGAR—
2025-05-132025-03-310001390478-25-000008EDGAR—
2024-11-132024-09-300001390478-24-000021EDGAR—
2024-08-132024-06-300001390478-24-000015EDGAR—
2024-05-142024-03-310001390478-24-000010EDGAR—
2023-11-092023-09-300001390478-23-000024EDGAR—
2023-08-102023-06-300001390478-23-000019EDGAR—
2023-05-112023-03-310001390478-23-000012EDGAR—
2022-11-142022-09-300001390478-22-000028EDGAR—
2022-08-112022-06-300001390478-22-000020EDGAR—
2022-05-122022-03-310001390478-22-000012EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-190001390478-26-000004EDGAR2K words
2026-03-110001104659-26-026384EDGAR—
2026-01-080001104659-26-001957EDGAR—
2025-11-120001390478-25-000021EDGAR—
2025-10-270001104659-25-102345EDGAR—
2025-10-030001104659-25-096643EDGAR—
2025-09-110001104659-25-089272EDGAR—
2025-08-120001390478-25-000017EDGAR—
2025-06-180001104659-25-060704EDGAR—
2025-06-060001104659-25-057308EDGAR—

432 total filings indexed. 400 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001390478
TickerSLS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6b2516275ef15930bac7ca6b025e6c11df975cdab10cb7c3d561d3df635d5178
parent: 8388b5c67bb225f8975ba81c5ddb0aa66046b82441972729ec4b248c1d9cba41
content hash: 58bae89b13bb44dcdc9d39a2d6c8c1c5b4598fa1f35339573a7c46023a3d3d86
signed: 2026-04-13T04:47:29.307Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf